Alexey V. Danilov M.D., Ph.D.

Photo of Alexey V. Danilov, M.D., Ph.D.
Faculty profile

Associate Professor of Medicine School of Medicine

Accepting new patients

4.9 out of 5 (151 Ratings, 32 Comments)


  • Cancer
  • Cancer and Blood Disorders

Special focus on

  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Lymphoma
  • Non-Hodgkin lymphoma


  • M.D., Yaroslavl State Medical Academy, Yaroslavl 1997
  • Ph.D., Yaroslavl State Medical Academy, Yaroslavl 2000
  • Residency:

    • Internal medicine, Brown University School of Medicine, 2007
  • Fellowship:

    • Hematology-oncology, Tufts Medical Center, Boston, 2010
  • Certifications:

    • American Board of Internal Medicine: internal medicine, 2007
    • American Board of Internal Medicine: medical oncology, 2010
    • American Board of Internal Medicine: hematology, 2012


Dr. Alexey Danilov is a physician with special expertise in lymphoma and chronic lymphocytic leukemia. In addition to taking care of patients with lymphoma and CLL, Dr. Danilov initiates and leads clinical trials and heads a research laboratory which investigates novel therapeutic targets in lymphoma. Importantly, in collaboration with industry, his research team translates bench discoveries into early-phase clinical trials, which are poised to improve lives of patients by developing safe and effective new treatments. Dr. Danilov is a Lymphoma Research Foundation Clinical Investigator and a Leukemia and Lymphoma Society Scholar in Clinical Research. He and his research team are recipients of numerous awards, including the Leukemia and Lymphoma Society Translational Research Program Award, American Society of Hematology Abstract Achievement Award, Gazzaniga Family Prize, Professor Albitski Prize and others. His research is consistently featured at national and international meetings.

Dr. Danilov developed new clinical trials which target the tumor-supporting niche; optimized treatment regimens for older patients with CLL; defined novel ways to target the tumor niche in lymphoma and CLL; discovered how novel class of drugs, CDK inhibitors, kill tumor cells.

Read more

Clinical Trials

The following clinical trials are currently accepting new participants:

Search all studies

Patient Ratings

4.9 out of 5 (151 Ratings, 32 Comments)

The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.

Patient Comments

  • Nov 28, 2018

    Having cancer is frightening. My appointments with Dr. Danilov are always reassuring and positive.

  • Nov 01, 2018

    Dr. Danilov is by far the my most favorite doctor that I've ever worked with on my health care. He's compassionate, he's so highly analytical and intelligent and... and direct but delivered with kindness, and I just can't even say enough about him. I rave about them to everyone I know. He's just... I find him endearing, I find him fascinating. Just... just an incredible human.

  • Oct 31, 2018

    Dr. Danilov is an excellent physician advising me on my rare blood cancer.

  • Oct 30, 2018

    I'm very happy with all of the providers at OHSU. Everyone has been very kind, considerate and helpful.

  • Oct 26, 2018

    Treated with respect. Nurses and doctors were great

  • Oct 13, 2018

    The Doctor was very informative and let me know exactly what his plan was to treat me and how he and his staff would help me.

  • Oct 12, 2018

    Very caring and knowledgeable; takes time with me.

  • Sep 18, 2018

    Very thorough and knowledgeable. Explained things in a very easy to understand way.

  • Sep 10, 2018

    Punctual, polite, caring, professional

  • Aug 28, 2018

    Easy to talk with and ask questions to. Discusses my situation completely.

Make an Appointment

503 494-7999

Physician Referrals

503 494-7999

I see patients at